SG11202001906PA - Enrichment of nkx6.1 and c-peptide co-expressing cells derived in vitro from stem cells - Google Patents

Enrichment of nkx6.1 and c-peptide co-expressing cells derived in vitro from stem cells

Info

Publication number
SG11202001906PA
SG11202001906PA SG11202001906PA SG11202001906PA SG11202001906PA SG 11202001906P A SG11202001906P A SG 11202001906PA SG 11202001906P A SG11202001906P A SG 11202001906PA SG 11202001906P A SG11202001906P A SG 11202001906PA SG 11202001906P A SG11202001906P A SG 11202001906PA
Authority
SG
Singapore
Prior art keywords
enrichment
vitro
peptide
stem cells
expressing cells
Prior art date
Application number
SG11202001906PA
Other languages
English (en)
Inventor
Jeannette Kirkegaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of SG11202001906PA publication Critical patent/SG11202001906PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202001906PA 2017-09-11 2018-09-11 Enrichment of nkx6.1 and c-peptide co-expressing cells derived in vitro from stem cells SG11202001906PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17190412 2017-09-11
PCT/EP2018/074390 WO2019048690A1 (en) 2017-09-11 2018-09-11 ENRICHMENT OF CELLS COEXPRESSING NKX6.1 AND PEPTIDE C, IN VITRO DERIVATIVES FROM STEM CELLS

Publications (1)

Publication Number Publication Date
SG11202001906PA true SG11202001906PA (en) 2020-04-29

Family

ID=59846503

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202001906PA SG11202001906PA (en) 2017-09-11 2018-09-11 Enrichment of nkx6.1 and c-peptide co-expressing cells derived in vitro from stem cells

Country Status (14)

Country Link
US (1) US20200199540A1 (pt)
EP (1) EP3681992A1 (pt)
JP (1) JP7389020B2 (pt)
KR (1) KR20200051664A (pt)
AU (1) AU2018330499A1 (pt)
BR (1) BR112020004428A2 (pt)
CA (1) CA3074910A1 (pt)
CO (1) CO2020003122A2 (pt)
IL (1) IL272734A (pt)
MA (1) MA50279A (pt)
MX (1) MX2020002421A (pt)
RU (1) RU2020111055A (pt)
SG (1) SG11202001906PA (pt)
WO (1) WO2019048690A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113728090B (zh) 2019-04-08 2024-04-05 诺和诺德股份有限公司 从干细胞衍生的定形内胚层生成胰腺内胚层
CN114729323A (zh) 2019-11-22 2022-07-08 诺和诺德股份有限公司 旋转聚集的神经微球及其应用
WO2023203208A1 (en) 2022-04-21 2023-10-26 Evotec International Gmbh New cell populations and means and methods for their differentiation and preservation
WO2024008810A1 (en) 2022-07-06 2024-01-11 Novo Nordisk A/S Differentiation of stem cells to pancreatic endocrine cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471540A1 (en) 2001-12-28 2003-07-10 Cellartis Ab A method for the establishment of a pluripotent human blastocyst-derived stem cell line
GB2445338A (en) 2005-10-07 2008-07-02 Cellartis Ab A method for obtaining a xeno-free HBS cell line
US7695965B2 (en) * 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
US8278106B2 (en) * 2008-11-14 2012-10-02 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
CN108220224A (zh) 2011-06-21 2018-06-29 诺沃—诺迪斯克有限公司 自多潜能干细胞有效诱导定形内胚层
JP6470687B2 (ja) 2012-09-03 2019-02-13 ノヴォ ノルディスク アー／エス 小分子を用いた多能性幹細胞からの膵臓内胚葉の作製
EP2938722B1 (en) * 2012-12-31 2021-12-08 Janssen Biotech, Inc. Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
WO2014138671A2 (en) * 2013-03-08 2014-09-12 Viacyte, Inc. Cryopreservation, hibernation and room temperature storage of encapulated pancreatic endoderm cell aggregates
US8859286B2 (en) * 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
WO2015028614A1 (en) 2013-08-30 2015-03-05 Novo Nordisk A/S Generation of endocrine progenitor cells from human pluripotent stem cells using small molecules
JP7123802B2 (ja) * 2016-02-24 2022-08-23 ノヴォ ノルディスク アー／エス ヒト多能性幹細胞由来内分泌前駆細胞からの機能的ベータ細胞の産生

Also Published As

Publication number Publication date
CA3074910A1 (en) 2019-03-14
WO2019048690A1 (en) 2019-03-14
US20200199540A1 (en) 2020-06-25
RU2020111055A3 (pt) 2022-04-22
IL272734A (en) 2020-04-30
JP7389020B2 (ja) 2023-11-29
CO2020003122A2 (es) 2020-06-19
JP2020532978A (ja) 2020-11-19
MA50279A (fr) 2020-07-22
BR112020004428A2 (pt) 2020-09-08
CN111108190A (zh) 2020-05-05
RU2020111055A (ru) 2021-09-17
KR20200051664A (ko) 2020-05-13
MX2020002421A (es) 2020-07-13
EP3681992A1 (en) 2020-07-22
AU2018330499A1 (en) 2020-04-09

Similar Documents

Publication Publication Date Title
IL272734A (en) Enrichment of NKX6.1 and C-PEPTIDE cells generated from stem cells in vitro
AU201811385S (en) Network extender
GB2549822B (en) A method of differentiating or promoting the differentiation of NKX6.1/PDX1+pancreatic progenitor cells into non-native pancreatic ß cells in vitro
PL3361057T3 (pl) Turbina o niskich wymaganiach nadmiernej prędkości i sposób działania
SG10201810723VA (en) Improved t cell compositions
AU201715353S (en) Earrings
AU201716573S (en) Watch
IL275037A (en) CRISPR-CAS9-modified CD34+ human hematopoietic stem and progenitor cells and uses thereof
EP3464569A4 (en) IN VITRO METHODS FOR DIFFERENTIATING STEM CELLS INTO NEURONES AND GENERATED NEURONES USING THE SAME IN VITRO METHODS FOR DIFFERENTIATING STEM CELLS IN NEURONES
IL274291A (en) Compounds and their use in the proliferation of stem cells and/or progenitor cells
USD751938S1 (en) Watch face
CA181437S (en) Capsule
EP3571211A4 (en) ADENOSINE ANALOGUE AND ITS USE IN THE REGULATION OF CIRCADIAN CLOCK
AU363559S (en) Plant container
AU201811799S (en) Full face mask and snorkel
AU201716572S (en) Watch
USD772750S1 (en) Combination digital and analog timepiece face
EP3277260A4 (en) Erodium crassifolium l'her plant extracts and uses thereof
WO2016014786A3 (en) Pigment epithelium-derived factor (pedf) and peptide derivatives thereof for use in osteoblast differentiation and bone growth
EP3438251A4 (en) SPECIFIC PLURIPOTENT STEM CELL STIMULATED BY DIFFERENTIATION
AU363825S (en) Wearable semiochemical retainer
AU201811957S (en) Wearable sleep enhancement system
CA176212S (en) Snowrider
CA176866S (en) Wake up light
CA176867S (en) Wake up light